SAN DIEGO, April 14, 2011 /PRNewswire/ -- Gen-Probe
Incorporated (NASDAQ: GPRO) announced today that the Company will
release its first quarter 2011 financial results on Thursday, April 28, 2011 at approximately
4:00 pm Eastern Time (ET). The
announcement will be followed by a conference call with management
at 4:30 pm ET.
The conference call will be webcast live and may be accessed on
the investors section of the Company's web site at
www.gen-probe.com. An archived version of the webcast will be
available on the same web site for at least 90 days. A telephone
replay also will be available for 24 hours after the call ends. To
access the replay, please call 800-839-5573 (US) or 402-220-2075
(international).
About Gen-Probe
Gen-Probe is a global leader in the development, manufacture and
marketing of rapid, accurate and cost-effective molecular
diagnostic products and services that are used primarily to
diagnose human diseases, screen donated human blood, and ensure
transplant compatibility. Gen-Probe has approximately 28
years of expertise in nucleic acid testing (NAT), and received the
2004 National Medal of Technology, America's highest honor for
technological innovation, for developing NAT assays for blood
screening. Gen-Probe is headquartered in San Diego and employs approximately 1,400
people. For more information, go to www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations,
beliefs, plans, objectives, assumptions or future events or
performance are not historical facts and are forward-looking
statements. Forward-looking statements are not guarantees of
performance. They involve known and unknown risks, uncertainties
and assumptions that may cause actual results to differ materially
from those expressed or implied. For information about risks
and uncertainties we face and a discussion of our financial
statements and footnotes, see documents we have filed with the SEC,
including our most recent Form 10-K, and all subsequent periodic
filings. We assume no obligation and expressly disclaim any
duty to update any forward-looking statement to reflect events or
circumstances after the date of this press release or to reflect
the occurrence of unanticipated events.
SOURCE Gen-Probe Incorporated